In the first half of 2021, German start-ups were able to secure more capital than ever before: Almost 7.6 billion euros flowed into the start-ups. In the second half of the year, too, the total already exceeded expectations. While venture capital reaches a new level across industries, too little of the money arrives at medical technology start-ups. In an international comparison, they are underfunded – even though Germany is the largest MedTech location in Europe and the industry is benefiting from the pandemic and digitization.
So what is it that scares off donors? And can the sluggish flow of capital endanger Germany’s status in the industry? Jan Thede from the Axel Springer consulting agency hy and Hadi Saleh, CEO of CeramTec, a leading producer of high-performance ceramics for medical products, give the answer. Industry experts agree that MedTech startups have great potential to attract more attention to investors.
We have an exclusive subscription offer for you as a Handelsblatt Today listener. Interested? Then take a look here.
If you have any comments, questions, criticism or praise about this episode, please write to us by email: [email protected]
Top jobs of the day
Find the best jobs now and
be notified by email.